Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 141 | KALV | KALVISTA PHARMACEUTICALS INC | Healthcare | 49,927.0 | $1.0M | 0.28% | +10K | +23.5% | $20.13 | +32.9% |
| 142 | — | KINIKSA PHARMACEUTICALS INTL | — | 20,300.0 | $977K | 0.27% | +4K | +23.5% | $48.15 | — |
| 143 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 41,445.0 | $968K | 0.27% | +8K | +23.5% | $23.36 | -12.0% |
| 144 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 5,698.0 | $963K | 0.27% | +1K | +23.6% | $169.02 | +34.7% |
| 145 | XFLT | XAI OCTAGN FLT RAT & ALT INM | Financial Services | 55,758.0 | $958K | 0.26% | NEW | — | $17.18 | +11.2% |
| 146 | GERN | GERON CORP | Healthcare | 620,795.0 | $925K | 0.26% | +118K | +23.5% | $1.49 | -6.0% |
| 147 | TGTX | TG THERAPEUTICS INC | Healthcare | 26,930.0 | $895K | 0.25% | +5K | +23.5% | $33.22 | +22.8% |
| 148 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 15,836.0 | $895K | 0.25% | +3K | +23.6% | $56.49 | -8.3% |
| 149 | ZLAB | ZAI LAB LTD | Healthcare | 47,511.0 | $894K | 0.25% | +9K | +23.5% | $18.81 | +8.1% |
| 150 | TCPC | BLACKROCK TCP CAPITAL CORP | Financial Services | 247,315.0 | $893K | 0.25% | +35K | +16.5% | $3.61 | +18.6% |
| 151 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 3,449.0 | $891K | 0.25% | +657.0 | +23.5% | $258.32 | +22.4% |
| 152 | LGND | LIGAND PHARMACEUTICALS INC | Healthcare | 4,453.0 | $889K | 0.24% | +848.0 | +23.5% | $199.65 | +9.7% |
| 153 | BIIB | BIOGEN INC | Healthcare | 4,848.0 | $889K | 0.24% | +925.0 | +23.6% | $183.33 | +5.2% |
| 154 | EXEL | EXELIXIS INC | Healthcare | 20,651.0 | $886K | 0.24% | +4K | +23.5% | $42.89 | +19.1% |
| 155 | PSEC | PROSPECT CAP CORP | Financial Services | 337,946.0 | $882K | 0.24% | -123K | -26.7% | $2.61 | -16.5% |
| 156 | HALO | HALOZYME THERAPEUTICS INC | Healthcare | 13,571.0 | $877K | 0.24% | +3K | +23.6% | $64.63 | +7.1% |
| 157 | — | ASCENDIS PHARMA A/S | — | 3,830.0 | $876K | 0.24% | +730.0 | +23.6% | $228.73 | — |
| 158 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 39,213.0 | $853K | 0.23% | +7K | +23.5% | $21.76 | -14.2% |
| 159 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 11,234.0 | $834K | 0.23% | +2K | +23.6% | $74.26 | -10.9% |
| 160 | ARDX | ARDELYX INC | Healthcare | 135,954.0 | $814K | 0.23% | +26K | +23.5% | $5.99 | +4.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%